Neville Rodie & Shaw’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $963K | Sell |
10,500
-145
| -1% | -$12.7K | 0.06% | 134 |
|
|
2026
Q1 | $907K | Hold |
10,645
| – | – | 0.07% | 129 |
|
|
2025
Q4 | $841K | Hold |
10,645
| – | – | 0.06% | 138 |
|
|
2025
Q3 | $851K | Hold |
10,645
| – | – | 0.06% | 140 |
|
|
2025
Q2 | $968K | Sell |
10,645
-1,130
| -10% | -$103K | 0.07% | 131 |
|
|
2025
Q1 | $1.1M | Sell |
11,775
-355
| -3% | -$31.8K | 0.09% | 123 |
|
|
2024
Q4 | $1.1M | Hold |
12,130
| – | – | 0.08% | 125 |
|
|
2024
Q3 | $1.26M | Hold |
12,130
| – | – | 0.09% | 119 |
|
|
2024
Q2 | $1.18M | Hold |
12,130
| – | – | 0.09% | 120 |
|
|
2024
Q1 | $1.09M | Sell |
12,130
-200
| -2% | -$16.9K | 0.08% | 128 |
|
|
2023
Q4 | $983K | Sell |
12,330
-300
| -2% | -$22.6K | 0.08% | 131 |
|
|
2023
Q3 | $898K | Sell |
12,630
-350
| -3% | -$26.2K | 0.08% | 130 |
|
|
2023
Q2 | $1M | Hold |
12,980
| – | – | 0.09% | 127 |
|
|
2023
Q1 | $975K | Sell |
12,980
-58
| -0.4% | -$4.31K | 0.09% | 127 |
|
|
2022
Q4 | $1.03M | Hold |
13,038
| – | – | 0.1% | 121 |
|
|
2022
Q3 | $916K | Hold |
13,038
| – | – | 0.09% | 123 |
|
|
2022
Q2 | $1.04M | Hold |
13,038
| – | – | 0.09% | 120 |
|
|
2022
Q1 | $996K | Hold |
13,038
| – | – | 0.07% | 137 |
|
|
2021
Q4 | $1.11M | Hold |
13,038
| – | – | 0.08% | 137 |
|
|
2021
Q3 | $986K | Sell |
13,038
-400
| -3% | -$31.8K | 0.08% | 135 |
|
|
2021
Q2 | $1.09M | Buy |
13,438
+58
| +0.4% | +$4.74K | 0.08% | 129 |
|
|
2021
Q1 | $1.05M | Sell |
13,380
-456
| -3% | -$35.7K | 0.09% | 128 |
|
|
2020
Q4 | $1.18M | Hold |
13,836
| – | – | 0.1% | 112 |
|
|
2020
Q3 | $1.07M | Hold |
13,836
| – | – | 0.1% | 113 |
|
|
2020
Q2 | $1.01M | Sell |
13,836
-200
| -1% | -$14.2K | 0.1% | 112 |
|
|
2020
Q1 | $932K | Sell |
14,036
-75
| -0.5% | -$5.29K | 0.11% | 113 |
|
|
2019
Q4 | $972K | Hold |
14,111
| – | – | 0.1% | 128 |
|
|
2019
Q3 | $1.04M | Hold |
14,111
| – | – | 0.11% | 120 |
|
|
2019
Q2 | $1.01M | Sell |
14,111
-225
| -2% | -$16K | 0.11% | 124 |
|
|
2019
Q1 | $983K | Sell |
14,336
-581
| -4% | -$37.5K | 0.1% | 123 |
|
|
2018
Q4 | $888K | Sell |
14,917
-1,429
| -9% | -$89.4K | 0.11% | 124 |
|
|
2018
Q3 | $1.09M | Sell |
16,346
-600
| -4% | -$40K | 0.11% | 121 |
|
|
2018
Q2 | $1.1M | Sell |
16,946
-2,549
| -13% | -$167K | 0.12% | 122 |
|
|
2018
Q1 | $1.4M | Sell |
19,495
-950
| -5% | -$68.4K | 0.15% | 109 |
|
|
2017
Q4 | $1.54M | Sell |
20,445
-775
| -4% | -$56.6K | 0.16% | 107 |
|
|
2017
Q3 | $1.55M | Sell |
21,220
-3,350
| -14% | -$241K | 0.17% | 103 |
|
|
2017
Q2 | $1.82M | Sell |
24,570
-1,525
| -6% | -$113K | 0.21% | 96 |
|
|
2017
Q1 | $1.91M | Sell |
26,095
-1,050
| -4% | -$73.5K | 0.22% | 90 |
|
|
2016
Q4 | $1.78M | Sell |
27,145
-875
| -3% | -$60K | 0.21% | 92 |
|
|
2016
Q3 | $2.08M | Sell |
28,020
-25
| -0.1% | -$1.85K | 0.24% | 93 |
|
|
2016
Q2 | $2.05M | Sell |
28,045
-616
| -2% | -$43.9K | 0.25% | 93 |
|
|
2016
Q1 | $2.02M | Buy |
28,661
+675
| +2% | +$44.9K | 0.25% | 90 |
|
|
2015
Q4 | $1.86M | Sell |
27,986
-75
| -0.3% | -$4.99K | 0.22% | 91 |
|
|
2015
Q3 | $1.78M | Hold |
28,061
| – | – | 0.22% | 98 |
|
|
2015
Q2 | $1.83M | Sell |
28,061
-331
| -1% | -$22.5K | 0.2% | 104 |
|
|
2015
Q1 | $1.97M | Sell |
28,392
-3,025
| -10% | -$209K | 0.2% | 106 |
|
|
2014
Q4 | $2.17M | Buy |
31,417
+900
| +3% | +$60.8K | 0.22% | 101 |
|
|
2014
Q3 | $1.99M | Sell |
30,517
-76
| -0.2% | -$5.01K | 0.2% | 102 |
|
|
2014
Q2 | $2.09M | Sell |
30,593
-200
| -0.6% | -$13.4K | 0.21% | 98 |
|
|
2014
Q1 | $2M | Sell |
30,793
-39
| -0.1% | -$2.46K | 0.22% | 92 |
|
|
2013
Q4 | $2.01M | Sell |
30,832
-4,275
| -12% | -$274K | 0.22% | 89 |
|
|
2013
Q3 | $2.08M | Buy |
35,107
+25
| +0.1% | +$1.48K | 0.24% | 94 |
|
|
2013
Q2 | $2.01M | Buy |
+35,082
| New | +$2.08M | 0.24% | 95 |
|
Other funds holding CL
SP
PAM
CIM
AAMU
JIC
WG
Neville Rodie & Shaw's CL Position: Q2 2026 in Review
Neville Rodie & Shaw reduced its Colgate-Palmolive (CL) stake by 1.4% in Q2 2026, selling an estimated $12.7K and leaving 10,500 shares worth $963K. The position accounts for 0.06% of the portfolio, ranked #134.
Neville Rodie & Shaw first reported a position in CL in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.17M in Q4 2014. 623 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Neville Rodie & Shaw held 10,500 shares of Colgate-Palmolive worth $963K as of Q2 2026.
- Neville Rodie & Shaw sold 145 Colgate-Palmolive shares in Q2 2026, an estimated $12.7K.
- Colgate-Palmolive made up 0.06% of Neville Rodie & Shaw's portfolio in Q2 2026, its #134 holding.
- Neville Rodie & Shaw first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 53 quarters since.
- Neville Rodie & Shaw's Colgate-Palmolive position peaked at $2.17M in Q4 2014.
- 623 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Neville Rodie & Shaw's 13F filing for Q2 2026, filed 6 Jul 2026.